FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133973692> ?p ?o ?g. }

• W2133973692 endingPage "4581" @default.
• W2133973692 startingPage "4574" @default.
• W2133973692 abstract "ABSTRACT This study was conducted to evaluate risk factors for mortality and treatment outcome of bloodstream infections due to extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae (ESBL-EK). ESBL production in stored K. pneumoniae and E. coli blood isolates from Jan 1998 to Dec 2002 was phenotypically determined according to NCCLS guidelines and/or the double-disk synergy test. A total of 133 patients with ESBL-EK bacteremia, including 66 patients with ESBL-producing K. pneumoniae and 67 with ESBL-producing E. coli , were enrolled. The overall 30-day mortality rate was 25.6% (34 of 133). Independent risk factors for mortality were severe sepsis, peritonitis, neutropenia, increasing Acute Physiology and Chronic Health Evaluation II score, and administration of broad-spectrum cephalosporin as definitive antimicrobial therapy ( P < 0.05 for each of these risk factors). In 117 of the 133 patients, excluding 16 patients who died within 3 days after blood culture sample acquisition, the 30-day mortality rates according to definitive antibiotics were as follows: carbapenem, 12.9% (8 of 62); ciprofloxacin, 10.3% (3 of 29); and others, such as cephalosporin or an aminoglycoside, 26.9% (7 of 26). When patients who received appropriate definitive antibiotics, such as carbapenem or ciprofloxacin, were evaluated, mortality in patients receiving inappropriate empirical antimicrobial therapy was found not to be significantly higher than mortality in those receiving appropriate empirical antimicrobial therapy (18.9 versus 15.5%; P = 0.666). Carbapenem and ciprofloxacin were the most effective antibiotics in antimicrobial therapy for ESBL-EK bacteremia. A delay in appropriate definitive antimicrobial therapy was not associated with higher mortality if antimicrobial therapy was adjusted appropriately according to the susceptibility results. Our data suggest that more prudent use of carbapenem as empirical antibiotic may be reasonable." @default.
• W2133973692 created "2016-06-24" @default.
• W2133973692 creator A5016707928 @default.
• W2133973692 creator A5026549320 @default.
• W2133973692 creator A5036758177 @default.
• W2133973692 creator A5048253912 @default.
• W2133973692 creator A5050991188 @default.
• W2133973692 creator A5058103007 @default.
• W2133973692 creator A5067286446 @default.
• W2133973692 creator A5081894061 @default.
• W2133973692 date "2004-12-01" @default.
• W2133973692 modified "2023-10-17" @default.
• W2133973692 title "Bloodstream Infections Due to Extended-Spectrum β <b>-</b> Lactamase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> : Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy" @default.
• W2133973692 cites W1539678687 @default.
• W2133973692 cites W1855450948 @default.
• W2133973692 cites W1921319550 @default.
• W2133973692 cites W2003578597 @default.
• W2133973692 cites W2018825808 @default.
• W2133973692 cites W2027672571 @default.
• W2133973692 cites W2035755223 @default.
• W2133973692 cites W2044467706 @default.
• W2133973692 cites W2046492569 @default.
• W2133973692 cites W2046523183 @default.
• W2133973692 cites W2071637551 @default.
• W2133973692 cites W2073060575 @default.
• W2133973692 cites W2078340635 @default.
• W2133973692 cites W2081919994 @default.
• W2133973692 cites W2088612111 @default.
• W2133973692 cites W2103573127 @default.
• W2133973692 cites W2112459888 @default.
• W2133973692 cites W2115255353 @default.
• W2133973692 cites W2120588426 @default.
• W2133973692 cites W2127429285 @default.
• W2133973692 cites W2128940357 @default.
• W2133973692 cites W2141235874 @default.
• W2133973692 cites W2142336791 @default.
• W2133973692 cites W2145645537 @default.
• W2133973692 cites W2153868993 @default.
• W2133973692 cites W2157377702 @default.
• W2133973692 cites W2159585072 @default.
• W2133973692 cites W2599527603 @default.
• W2133973692 cites W4293242440 @default.
• W2133973692 cites W4301177039 @default.
• W2133973692 doi "https://doi.org/10.1128/aac.48.12.4574-4581.2004" @default.
• W2133973692 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/529180" @default.
• W2133973692 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15561828" @default.
• W2133973692 hasPublicationYear "2004" @default.
• W2133973692 type Work @default.
• W2133973692 sameAs 2133973692 @default.
• W2133973692 citedByCount "259" @default.
• W2133973692 countsByYear W21339736922012 @default.
• W2133973692 countsByYear W21339736922013 @default.
• W2133973692 countsByYear W21339736922014 @default.
• W2133973692 countsByYear W21339736922015 @default.
• W2133973692 countsByYear W21339736922016 @default.
• W2133973692 countsByYear W21339736922017 @default.
• W2133973692 countsByYear W21339736922018 @default.
• W2133973692 countsByYear W21339736922019 @default.
• W2133973692 countsByYear W21339736922020 @default.
• W2133973692 countsByYear W21339736922021 @default.
• W2133973692 countsByYear W21339736922022 @default.
• W2133973692 countsByYear W21339736922023 @default.
• W2133973692 crossrefType "journal-article" @default.
• W2133973692 hasAuthorship W2133973692A5016707928 @default.
• W2133973692 hasAuthorship W2133973692A5026549320 @default.
• W2133973692 hasAuthorship W2133973692A5036758177 @default.
• W2133973692 hasAuthorship W2133973692A5048253912 @default.
• W2133973692 hasAuthorship W2133973692A5050991188 @default.
• W2133973692 hasAuthorship W2133973692A5058103007 @default.
• W2133973692 hasAuthorship W2133973692A5067286446 @default.
• W2133973692 hasAuthorship W2133973692A5081894061 @default.
• W2133973692 hasBestOaLocation W21339736922 @default.
• W2133973692 hasConcept C104317684 @default.
• W2133973692 hasConcept C126322002 @default.
• W2133973692 hasConcept C179755657 @default.
• W2133973692 hasConcept C2776685102 @default.
• W2133973692 hasConcept C2776694085 @default.
• W2133973692 hasConcept C2777058267 @default.
• W2133973692 hasConcept C2777063308 @default.
• W2133973692 hasConcept C2778512257 @default.
• W2133973692 hasConcept C2779443120 @default.
• W2133973692 hasConcept C2779473907 @default.
• W2133973692 hasConcept C4937899 @default.
• W2133973692 hasConcept C501593827 @default.
• W2133973692 hasConcept C547475151 @default.
• W2133973692 hasConcept C55493867 @default.
• W2133973692 hasConcept C64778159 @default.
• W2133973692 hasConcept C71924100 @default.
• W2133973692 hasConcept C86803240 @default.
• W2133973692 hasConcept C89423630 @default.
• W2133973692 hasConceptScore W2133973692C104317684 @default.
• W2133973692 hasConceptScore W2133973692C126322002 @default.
• W2133973692 hasConceptScore W2133973692C179755657 @default.
• W2133973692 hasConceptScore W2133973692C2776685102 @default.
• W2133973692 hasConceptScore W2133973692C2776694085 @default.
• W2133973692 hasConceptScore W2133973692C2777058267 @default.
• W2133973692 hasConceptScore W2133973692C2777063308 @default.
• W2133973692 hasConceptScore W2133973692C2778512257 @default.

• next